Portage Biotech (PRTG) Financials

$4.70

$-0.47 (-9.09%)

As on 05-Nov-2025 09:30EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

9.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-5.46	-14.30	-12.07	-6.76	-4.28	-3.71
Cash Flow from Investing Activities	--	2.81	-0.62	-0.62	-0.86	-0.45
Cash from Financing Activities	2.10	5.97	-0.12	27.35	4.76	0.70
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS ($)	-6.29	-76.16	-5.94	-1.26	-1.32	-0.49
Cash EPS ($)	-6.26	-76.11	-5.94	-1.26	-1.32	-0.49
Adjusted Book Value ($)	--	4.07	4.32	9.08	8.43	8.79
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-5.08	-14.45	-0.69	-0.51	-0.36	-0.34
Free Cash Flow per Share ($)	-5.08	-14.45	-0.69	-0.51	-0.27	-0.34

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	-342.98	-188.08	-106.07	-15.14	-15.69	-5.24
ROE (%)	-347.11	-188.19	-106.07	-15.15	-15.99	-5.44
ROA (%)	-135.29	-140.94	-71.21	-9.13	-9.10	-3.07
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	59.36	-15.70	49.40	-17.97	-121.56	-293.37
Net Profit Growth (%)	91.02	27.98	-520.10	-6.55	-196.89	-102.39
EPS Growth (%)	0.92	-11.82	-3.70	0.04	-1.71	0.48
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	-1.47	-0.01	-0.52	-5.20	-21.25	-0.19
Price / Book Value	-80.92	0.14	0.72	0.72	3.32	0.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	0.24	-2.78	-4.13	-23.54	-0.24
Close Price ($)	9.25	11.27	61.80	131.40	559.40	182.00
High Price ($)	23.01	88.00	239.80	899.53	828.20	400.00
Low Price ($)	2.10	6.80	46.80	127.20	165.00	120.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	--	0.01	--	--	0.00	0.04
Short term debt to equity ratio	--	0.01	--	--	0.00	0.00
Current Ratio	2.02	2.67	7.33	31.71	1.54	1.48
Quick Ratio	--	--	--	--	2.01	1.28
Interest Coverage	-2,472.67	-570.41	-1,752.89	-725.02	-149.30	-21.41

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	2,556.75	84,372.75	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--